HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Heng Lim Selected Research

impacarzinum (5531)

8/2022Willingness-to-pay for cancer treatment and outcome: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Heng Lim Research Topics

Disease

1Pain (Aches)
08/2022
1Nausea
03/2019
1Vomiting
03/2019
1Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2018
1Gout
01/2018

Drug/Important Bio-Agent (IBA)

1impacarzinum (5531)IBA
08/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2019
1Olanzapine (Zyprexa)FDA Link
03/2019
1Allopurinol (Remid)FDA LinkGeneric
01/2018
1Probenecid (Benemid)FDA LinkGeneric
01/2018
1HLA-B Antigens (HLA-B)IBA
01/2018

Therapy/Procedure

1Drug Therapy (Chemotherapy)
03/2019
1Therapeutics
01/2018